Growth Metrics

Stemtech (STEK) Change in Accured Expenses (2020 - 2025)

Stemtech (STEK) has disclosed Change in Accured Expenses for 6 consecutive years, with -$709487.0 as the latest value for Q3 2025.

  • Quarterly Change in Accured Expenses rose 54.48% to -$709487.0 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $1.8 million through Sep 2025, up 1304.96% year-over-year, with the annual reading at $1.8 million for FY2024, 89.07% up from the prior year.
  • Change in Accured Expenses hit -$709487.0 in Q3 2025 for Stemtech, down from $347966.0 in the prior quarter.
  • In the past five years, Change in Accured Expenses ranged from a high of $1.8 million in Q4 2024 to a low of -$1.6 million in Q3 2024.
  • Historically, Change in Accured Expenses has averaged $173753.5 across 5 years, with a median of $267170.0 in 2021.
  • Biggest five-year swings in Change in Accured Expenses: soared 1828.25% in 2021 and later plummeted 589.69% in 2024.
  • Year by year, Change in Accured Expenses stood at $1.2 million in 2021, then plummeted by 189.56% to -$1.1 million in 2022, then skyrocketed by 111.82% to $128793.0 in 2023, then skyrocketed by 1304.96% to $1.8 million in 2024, then plummeted by 139.21% to -$709487.0 in 2025.
  • Business Quant data shows Change in Accured Expenses for STEK at -$709487.0 in Q3 2025, $347966.0 in Q2 2025, and $361521.0 in Q1 2025.